Health ❯Public Health
Healthcare Access Access to Healthcare Emergency Services AI Acceptance Medical Errors Healthcare Services Hospitalization Medical Attention Clinical Reviews
Phase-3 results demonstrated a 20% higher cure rate over meropenem with forecasts valuing the drug at $9 billion globally